Altered Immune Surveillance of B and T Cells in Patients with Persistent Residual Lung Abnormalities 12 Months After Severe COVID-19

Overview

Journal Respir Res

Date 2025 Jan 18

PMID 39827348

Authors

Julio Flores-Gonzalez

Ivette Buendia-Roldan

Fernanda Tellez-Quijada

Carlos Pena-Bates

Lucero A Ramon-Luing

Armando Castorena-Maldonado

Ramces Falfan-Valencia

Gloria Perez-Rubio

Moises Selman

Leslie Chavez-Galan

Affiliations

Soon will be listed here.

Abstract

Background: Post-COVID-19 respiratory sequelae often involve lung damage, which is called residual lung abnormalities, and potentially lead to chronic respiratory issues. The adaptive immune response, involving T-cells and B-cells, plays a critical role in pathogen control, inflammation, and tissue repair. However, the link between immune dysregulation and the development of residual lung abnormalities remains unclear.

Methods: 109 patients discharged with residual lung abnormalities after a critical COVID-19 were followed for 12 months and divided as full recovery patients (FRG, n = 88) and persistent lung abnormalities (PLAG, n = 21). Cell profiling analysis was done using flow cytometry at 24 h of not antigen-specific in vitro stimulation. Plasma or supernatant levels of IFN-g, IL-4, IL-10, IgM, and IgG were assessed, and 10 patients (5 FRG, 5 PLAG) were randomly selected for detailed immune cell phenotyping and functional analysis of peripheral blood mononuclear cells using flow cytometry.

Results: Compared to the FRG group, PLAG exhibited an increase of unswitched (p = 0.0159) and decreased double-negative activated B-cells (p = 0.0317), systemic IL-10 levels were lower, displayed reduced frequency of total B-cells, and impaired spontaneous IgM (p = 0.0357) and IgG (p = 0.0079) release in culture. Regarding T-cells, PLAG patients showed a reduction in effector memory CD4 + cells (p = 0.0159) and an increase in CD4 + TEMRA cells (p = 0.0079) following in vitro stimulation. Notably, the PLAG group also exhibited higher frequencies of central memory CD4 + Th2 (GATA3+) T-cells in response to activation than the FRG group (p = 0.0079).

Conclusions: Patients with residual lung abnormalities 12 months post-critical COVID-19 exhibit impaired B-cell function, increased unswitched B-cells, and higher frequencies of CD4 + TEMRA T-cells following in vitro activation. These immune imbalances may contribute to ongoing lung dysfunction and warrant further investigation as a potential mechanism in residual lung abnormalities. Larger studies are necessary to confirm these findings.

References

Camponeschi A, Klasener K, Sundell T, Lundqvist C, Manna P, Ayoubzadeh N . Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. J Exp Med. 2022; 219(9). PMC: 9280193. DOI: 10.1084/jem.20220201. View

Lindner H, Velasquez S, Thiel M, Kirschning T . Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19. Front Immunol. 2021; 12:602130. PMC: 7966717. DOI: 10.3389/fimmu.2021.602130. View

Thieme C, Abou-El-Enein M, Fritsche E, Anft M, Paniskaki K, Skrzypczyk S . Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity. Allergy. 2021; 76(8):2595-2599. PMC: 8251309. DOI: 10.1111/all.14827. View

Kratzer B, Gattinger P, Trapin D, Ettel P, Kormoczi U, Rottal A . Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19. Allergy. 2024; 79(9):2482-2501. DOI: 10.1111/all.16210. View

Haruo Fernandes de Lima M, Machado C, Nascimento D, Silva C, Toller-Kawahisa J, Rodrigues T . The TIGIT T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation. Sci Rep. 2023; 13(1):13599. PMC: 10442317. DOI: 10.1038/s41598-023-39924-7. View

Joller N, Lozano E, Burkett P, Patel B, Xiao S, Zhu C . Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014; 40(4):569-81. PMC: 4070748. DOI: 10.1016/j.immuni.2014.02.012. View

Jutant E, Meyrignac O, Beurnier A, Jais X, Pham T, Morin L . Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome. ERJ Open Res. 2022; 8(2). PMC: 8685862. DOI: 10.1183/23120541.00479-2021. View

Al-Aly Z, Bowe B, Xie Y . Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022; 28(7):1461-1467. PMC: 9307472. DOI: 10.1038/s41591-022-01840-0. View

Cai M, Xie Y, Topol E, Al-Aly Z . Three-year outcomes of post-acute sequelae of COVID-19. Nat Med. 2024; 30(6):1564-1573. PMC: 11186764. DOI: 10.1038/s41591-024-02987-8. View

10.

Proal A, VanElzakker M, Aleman S, Bach K, Boribong B, Buggert M . SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol. 2023; 24(10):1616-1627. DOI: 10.1038/s41590-023-01601-2. View

11.

Haruo Fernandes de Lima M, Hiroki C, Borges V, Cebinelli G, Santos J, Rosa M . Sepsis-Induced Immunosuppression Is Marked by an Expansion of a Highly Suppressive Repertoire of FOXP3+ T-Regulatory Cells Expressing TIGIT. J Infect Dis. 2021; 225(3):531-541. DOI: 10.1093/infdis/jiab405. View

12.

Queiroz M, das Neves P, Lima S, Lopes J, Torres M, Vallinoto I . Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front Cell Infect Microbiol. 2022; 12:922422. PMC: 9279918. DOI: 10.3389/fcimb.2022.922422. View

13.

Buendia-Roldan I, Martinez-Espinosa K, Aguirre M, Aguilar-Duran H, Palma-Lopez A, Palacios Y . Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio. Immun Inflamm Dis. 2024; 12(7):e1305. PMC: 11259001. DOI: 10.1002/iid3.1305. View

14.

Lenti M, Aronico N, Pellegrino I, Boveri E, Giuffrida P, Borrelli de Andreis F . Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19. Sci Rep. 2020; 10(1):20836. PMC: 7705651. DOI: 10.1038/s41598-020-77945-8. View

15.

Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M . Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front Immunol. 2022; 13:886431. PMC: 9226563. DOI: 10.3389/fimmu.2022.886431. View

16.

Paniskaki K, Konik M, Anft M, Heidecke H, Meister T, Pfaender S . Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19. Front Microbiol. 2023; 14:1196721. PMC: 10272838. DOI: 10.3389/fmicb.2023.1196721. View

17.

Heine G, Drozdenko G, Grun J, Chang H, Radbruch A, Worm M . Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur J Immunol. 2014; 44(6):1615-21. DOI: 10.1002/eji.201343822. View

18.

Piedra-Quintero Z, Wilson Z, Nava P, Guerau-de-Arellano M . CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity. Front Immunol. 2020; 11:597959. PMC: 7734206. DOI: 10.3389/fimmu.2020.597959. View

19.

Joung S, Weber B, Wu M, Liu Y, Tang A, Driver M . Serological response to vaccination in post-acute sequelae of COVID. BMC Infect Dis. 2023; 23(1):97. PMC: 9933819. DOI: 10.1186/s12879-023-08060-y. View

20.

Vazquez-Alejo E, Tarancon-Diez L, De La Sierra Espinar-Buitrago M, Genebat M, Calderon A, Perez-Cabeza G . Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study. J Clin Med. 2023; 12(10). PMC: 10219183. DOI: 10.3390/jcm12103539. View